Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EONS 2019 | Totally Implantable Vascular Access Device (TIVAD) service for patients with metastatic cancer

Matthew Fowler • 29 Sep 2019
EONS 2019
General

Matthew Fowler, BScN, MSc, Heart of England NHS Foundation Trust, Birmingham, UK, discusses the benefits of the introduction of a nurse-led Totally Implantable Vascular Access Device (TIVAD) service for patients with metastatic cancer. This interview took place at EONS 12 during the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain. CN34 –

More from Matthew Fowler

2:07
EONS safety work: Where do we go from here?
Matthew Fowler • 24 Sep 2020
1:13
EONS 2020 highlights
Matthew Fowler • 24 Sep 2020
2:26
Cytotoxic contamination in wards
Matthew Fowler • 29 Sep 2019
1:06
Multidisciplinary collaboration is key to advances in oncology nursing
Matthew Fowler • 22 Oct 2018

Related Videos

0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
3:10
PALOMA: subcutaneous amivantamab in advanced solid tumors
Natasha Leighl • 17 Apr 2024
The content of VJOncology is intended for healthcare professionals